Latest Stock Split Details
Key information about Chinook Therapeutics, Inc.'s most recent stock split
Developer API
Get KDNY split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 5.00 times fewer shares (a 1:5 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Chinook Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2020-10-02 | 1:5 | Yes | $2.80 | $0.56 |
About Chinook Therapeutics, Inc.
Company overview and industry information
Chinook Therapeutics, Inc. (KDNY) operates in the Biotechnology industry. The recent 1-for-5 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.